Header cover image

Global Established, Profitable and Undervalued

UPDATED Aug 11, 2022

Over $1bn in market cap, profitable and undervalued based on cash flows.

1,059 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
NBIXNeurocrine BiosciencesUS$104.889.3%21.0%US$10.0bUS$115.32PE821.7xE40.5%n/aPharmaceuticals & Biotech
SCBSCB X฿105.004.0%9.1%฿353.5b฿136.43PB0.8xE10.6%5.0%Banks
KBANKKasikornbank฿149.002.8%41.9%฿353.0b฿177.87PB0.7xE11.7%2.2%Banks
Page 45 of 45